Acadia Pharmaceuticals ACAD Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's total current assets?
- Acadia Pharmaceuticals (ACAD) reported total current assets of $1.1B in Q1 2026.
- How has Acadia Pharmaceuticals's total current assets changed year-over-year?
- Acadia Pharmaceuticals's total current assets increased by 25.8% year-over-year, from $870.94M to $1.1B.
- What is the long-term trend for Acadia Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's total current assets has grown at a 8.2% compound annual growth rate (CAGR), from $717.62M to $1.06B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.